priors.science/reviews/parkinsons-disease-management

Parkinsons Disease Management

The current evidence on 6 claims, ordered from most established to most contested. Each score is the panel’s evidence certainty — how firmly the literature supports the claim as stated.

6claims tracked
55primary papers reviewed
4 Jun 2026latest evidence review
Weeklyre-scored against new papers
2 Established · 4 Likely · 0 Uncertain · 0 Doubtful  |  four-reviewer panel · PICO Framework
SignalClaimStandingEvidence certaintyCorpus
StableLevodopa most effective for Parkinson's motor symptomsPD MOTOREstablished87%9
StableDeep brain stimulation improves motor function in advanced Parkinson'sPD DEVICEEstablished86%8
StableMonoamine oxidase B inhibitors provide motor benefit in Parkinson'sPD MOTORLikely83%9
StableNo proven disease-modifying therapy in Parkinson'sPD NEUROLikely83%10
StableContinuous infusion therapy reduces motor fluctuations in advanced Parkinson'sPD DEVICELikely82%8
StablePimavanserin improves Parkinson's psychosis without worsening motor symptomsPD NMLikely79%11
Standing — what the evidence certainty means
Established≥ 85%Strong, consistent evidence. Unlikely to change.
Likely65–84%Well supported, with some gaps or indirect evidence.
Uncertain40–64%Mixed or limited evidence. Genuinely open.
Doubtful15–39%Little support; the weight of evidence leans against it.
Refuted< 15%The evidence contradicts it — confidently false as stated.
Recent signal
strengthenedNew evidence raised the certainty since the last review.
weakenedNew evidence lowered the certainty since the last review.
newA claim added to the review recently.
StableNo recent change to the standing.
Standing, evidence certainty and corpus are always shown. The study behind each move, why it moved, and the sceptic’s challenge are delivered to subscribers.
Update your priors.Track this topic